Liusheng Zhu

AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies

Sean Caenepeel, Sean P. Brown, Brian Belmontes et al. · Cancer Discovery · 2018 · 408 citations · Full text

Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3

Michael G. Johnson, An‐Rong Li, Jiwen Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 103 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +8

Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist

Sean P. Brown, Paul J. Dransfield, Marc Vimolratana et al. · ACS Medicinal Chemistry Letters · 2012 · 88 citations · Full text

Partial Agonist 1, Pancreatic Islets, Biochemistry +12

Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles

Yingcai Wang, Jiwen Liu, Paul J. Dransfield et al. · ACS Medicinal Chemistry Letters · 2013 · 81 citations · Full text

Combinatorial Chemistry, Molecular Physiology, Biochemistry +13

Discovery and optimization of a novel series of liver X receptor-α agonists

Leping Li, Jiwen Liu, Liusheng Zhu et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 61 citations · Full text

Molecular Pharmacology, Novel Series, Biochemistry +8